173 related articles for article (PubMed ID: 35601606)
1. CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling.
Pu L; Singha M; Ramanujam J; Brylinski M
Oncotarget; 2022; 13():695-706. PubMed ID: 35601606
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors.
Singha M; Pu L; Stanfield BA; Uche IK; Rider PJF; Kousoulas KG; Ramanujam J; Brylinski M
BMC Cancer; 2022 Nov; 22(1):1211. PubMed ID: 36434556
[TBL] [Abstract][Full Text] [Related]
3. An integrated network representation of multiple cancer-specific data for graph-based machine learning.
Pu L; Singha M; Wu HC; Busch C; Ramanujam J; Brylinski M
NPJ Syst Biol Appl; 2022 Apr; 8(1):14. PubMed ID: 35487924
[TBL] [Abstract][Full Text] [Related]
4. Unlocking the Potential of Kinase Targets in Cancer: Insights from CancerOmicsNet, an AI-Driven Approach to Drug Response Prediction in Cancer.
Singha M; Pu L; Srivastava G; Ni X; Stanfield BA; Uche IK; Rider PJF; Kousoulas KG; Ramanujam J; Brylinski M
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627077
[TBL] [Abstract][Full Text] [Related]
5. Predicting anticancer hyperfoods with graph convolutional networks.
Gonzalez G; Gong S; Laponogov I; Bronstein M; Veselkov K
Hum Genomics; 2021 Jun; 15(1):33. PubMed ID: 34099048
[TBL] [Abstract][Full Text] [Related]
6. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
7. Modular within and between score for drug response prediction in cancer cell lines.
Wang S; Li J
Mol Omics; 2020 Feb; 16(1):31-38. PubMed ID: 31802092
[TBL] [Abstract][Full Text] [Related]
8. Network-based drug sensitivity prediction.
Ahmed KT; Park S; Jiang Q; Yeu Y; Hwang T; Zhang W
BMC Med Genomics; 2020 Dec; 13(Suppl 11):193. PubMed ID: 33371891
[TBL] [Abstract][Full Text] [Related]
9. RAMP: response-aware multi-task learning with contrastive regularization for cancer drug response prediction.
Lee K; Cho D; Jang J; Choi K; Jeong HO; Seo J; Jeong WK; Lee S
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36460623
[TBL] [Abstract][Full Text] [Related]
10. Prior knowledge-guided multilevel graph neural network for tumor risk prediction and interpretation via multi-omics data integration.
Yan H; Weng D; Li D; Gu Y; Ma W; Liu Q
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38670157
[TBL] [Abstract][Full Text] [Related]
11. Predicting Drug Response Based on Multi-Omics Fusion and Graph Convolution.
Peng W; Chen T; Dai W
IEEE J Biomed Health Inform; 2022 Mar; 26(3):1384-1393. PubMed ID: 34347616
[TBL] [Abstract][Full Text] [Related]
12. GraphCDR: a graph neural network method with contrastive learning for cancer drug response prediction.
Liu X; Song C; Huang F; Fu H; Xiao W; Zhang W
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34727569
[TBL] [Abstract][Full Text] [Related]
13. DualGCN: a dual graph convolutional network model to predict cancer drug response.
Ma T; Liu Q; Li H; Zhou M; Jiang R; Zhang X
BMC Bioinformatics; 2022 Apr; 23(Suppl 4):129. PubMed ID: 35428192
[TBL] [Abstract][Full Text] [Related]
14. Deep learning and multi-omics approach to predict drug responses in cancer.
Wang C; Lye X; Kaalia R; Kumar P; Rajapakse JC
BMC Bioinformatics; 2022 Nov; 22(Suppl 10):632. PubMed ID: 36443676
[TBL] [Abstract][Full Text] [Related]
15. Multi-channel graph attention autoencoders for disease-related lncRNAs prediction.
Sheng N; Huang L; Wang Y; Zhao J; Xuan P; Gao L; Cao Y
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35108355
[TBL] [Abstract][Full Text] [Related]
16. A cross-level information transmission network for hierarchical omics data integration and phenotype prediction from a new genotype.
He D; Xie L
Bioinformatics; 2021 Dec; 38(1):204-210. PubMed ID: 34390577
[TBL] [Abstract][Full Text] [Related]
17. Pathformer: a biological pathway informed transformer for disease diagnosis and prognosis using multi-omics data.
Liu X; Tao Y; Cai Z; Bao P; Ma H; Li K; Li M; Zhu Y; Lu ZJ
Bioinformatics; 2024 May; 40(5):. PubMed ID: 38741230
[TBL] [Abstract][Full Text] [Related]
18. TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.
Liu Q; Xie L
PLoS Comput Biol; 2021 Feb; 17(2):e1008653. PubMed ID: 33577560
[TBL] [Abstract][Full Text] [Related]
19. RefDNN: a reference drug based neural network for more accurate prediction of anticancer drug resistance.
Choi J; Park S; Ahn J
Sci Rep; 2020 Feb; 10(1):1861. PubMed ID: 32024872
[TBL] [Abstract][Full Text] [Related]
20. Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures.
Shtar G; Rokach L; Shapira B
PLoS One; 2019; 14(8):e0219796. PubMed ID: 31369568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
